Press release
Oncolytic Virus Therapy Market Scope and Forecast 2025-2034
The Oncolytic Virus Therapy Market Is Set To Grow At An Estimated CAGR Of 12.1% From 2025 To 2034, Rising From $4.8 Billion In 2024 To $14.5 Billion By 2034.On March 21, 2025, Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Oncolytic Virus Therapy market goods. The market study excludes key regions that are accelerating marketization. This section also gives the extent of different market segments and applications that could have an impact on the market in the future. Current trends and historical turning points form the basis of the enormous amount of data. The report includes information on market trends and development, growth drivers, emerging technologies, and the investment structure of the Oncolytic Virus Therapy market.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/47948
This report is also available in the following languages: Japanese (腫瘍溶解性ウイルス療法市場), Korea (온콜리틱 바이러스 치료 시장), china (溶瘤病毒治疗市场), French (Marché des thérapies virales oncolytiques), German (Markt für onkolytische Virustherapie), and Italy Markt für onkolytische Virustherapie), etc.
Key Companies Profiled
Amgen Inc., Merck & Co., Inc., AstraZeneca PLC, Oncolytics Biotech Inc., Genmab A/S, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Novartis AG, Pfizer Inc., Roche Holding AG, GSK (GlaxoSmithKline PLC), Sanofi S.A., Regeneron Pharmaceuticals, Inc., Immunocore Holdings PLC, Sorrento Therapeutics, Inc.
Market Segmentation
By Type of Virus
- Adenovirus
- Herpes simplex virus
- Vesicular stomatitis virus
- Reovirus
- Other viruses
By Application
- Melanoma
- Breast cancer
- Lung cancer
- Prostate cancer
- Others
By Route of Administration
- Intravenous
- Intratumoral
- Intranasal
Explore Full Report here:
https://exactitudeconsultancy.com/reports/47948/oncolytic-virus-therapy-market
If opting for the Global version of Oncolytic Virus Therapy Market; then the below country analysis would be included:
- North America (the USA, Canada, and Mexico)
- Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland, and the Rest of Europe)
- Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia, and the Rest of APAC)
- South America (Brazil, Argentina, Chile, Colombia, the Rest of the countries, etc.)
- the Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)
Buy Now
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=47948
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Oncolytic Virus Therapy market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Oncolytic Virus Therapy market.
Get Your Exclusive Offer with up to 30% Discount
https://exactitudeconsultancy.com/check-discount/47948
Reasons To Buy The Oncolytic Virus Therapy Market Report:
➼ In-depth analysis of the market on the global and regional levels.
➼ Major changes in market dynamics and competitive landscape.
➼ Segmentation on the basis of type, application, geography, and others.
➼ Historical and future market research in terms of size, share growth, volume, and sales.
➼ Major changes and assessment in market dynamics and developments.
➼ Emerging key segments and regions
➼ Key business strategies by major market players and their key methods
Our team is available 24/7 to assist and support our customers through reliable research.
Customization
-20% free customization.
-Five Countries can be added as per your choice.
-Five Companies can added as per your choice.
-Free customization up to 40 hours.
-Post-sales support for 1 year from the date of delivery.
Other Reports:
https://www.openpr.com/news/3757921/3d-printing-prosthetics-and-orthotics-market-outlook-and-future
https://www.openpr.com/news/3760427/cellular-concrete-market-regional-dynamics-shaping-future
https://www.openpr.com/news/3763002/enterprise-resource-planning-erp-market-share-size-price
https://www.openpr.com/news/3765534/internet-of-things-technology-market-growth-potential
https://www.openpr.com/news/3767727/particle-counter-market-insights-into-key-applications
https://www.openpr.com/news/3905751/automotive-commutator-market-trends-innovations-and-future
https://www.openpr.com/news/3774819/medical-tapes-and-bandages-market-growth-trends-and-forecast
https://www.openpr.com/news/3777572/electric-bus-market-current-insight-with-future-aspect-analysis
https://www.openpr.com/news/3779989/high-strength-aluminum-alloys-market-revenue-and-share-study
https://www.openpr.com/news/3782316/low-voc-adhesives-market-innovations-driving-sustainable
Explore additional sites:
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://exactitudeconsultancy.com/
About Us:
Exactitude Consultancy is a Market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you. So, whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way.
Contact us:
Exactitude Consultancy
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oncolytic Virus Therapy Market Scope and Forecast 2025-2034 here
News-ID: 3928322 • Views: …
More Releases from Exactitude Consultancy

Hypertrophic Cardiomyopathy Market to Reach USD 3.21 Billion by 2034, Growing at …
Introduction
Hypertrophic cardiomyopathy (HCM) is a genetic heart disorder characterized by abnormal thickening of the heart muscle, which can impair blood flow and increase the risk of arrhythmias, heart failure, and sudden cardiac death. Once managed primarily through beta-blockers, calcium channel blockers, and invasive procedures, the HCM treatment landscape has expanded with the approval of targeted therapies such as cardiac myosin inhibitors.
Growing awareness of genetic cardiovascular diseases, advances in molecular diagnostics,…

Biologics Contract Research Organization (CRO) Market to Reach USD 37.9 Billion …
Introduction
Biologics-including monoclonal antibodies, vaccines, recombinant proteins, and advanced therapies-are at the forefront of modern medicine. Their development, however, requires significant expertise, advanced infrastructure, and compliance with stringent regulatory standards. To meet these demands, pharmaceutical and biotechnology companies are increasingly outsourcing to Contract Research Organizations (CROs) specializing in biologics.
Biologics CROs provide services spanning discovery, preclinical research, clinical trials, bioanalytical testing, and regulatory consulting. With the rise of biologics, biosimilars, and advanced…

Niemann-Pick Disease Market to Reach USD 1.02 Billion by 2034, Growing at 10.6% …
Introduction
Niemann-Pick disease (NPD) is a group of rare, inherited lysosomal storage disorders caused by mutations that disrupt lipid metabolism, leading to progressive neurological decline, organ dysfunction, and premature death. The condition is categorized into several subtypes (A, B, and C), each varying in severity and progression.
Historically, treatment has been limited to palliative and supportive care. However, the landscape is changing rapidly with the development of enzyme replacement therapies (ERT), substrate…

PERK Inhibitors Market Forecast: USD 3.2 Billion by 2034 | Major Participants: N …
The fight against cancer and neurodegenerative diseases has brought the spotlight on the PERK (Protein kinase RNA-like endoplasmic reticulum kinase) pathway, a critical regulator of the unfolded protein response. PERK inhibitors are designed to modulate this pathway, reducing stress-induced cell death and playing a pivotal role in oncology, neurodegenerative research, and metabolic disorders. As precision medicine continues to gain traction, PERK inhibitors are attracting significant attention from both biotech firms…
More Releases for Virus
Zika Virus Vaccines Market 2022 | High rate of incidence of active Zika virus in …
Zika Virus Vaccines Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $18,697 million by 2022, registering a CAGR of 5.2% during the forecast period 2017-2022.Key opportunities include the need for vaccines for immunization & prevention of further spread of Zika virus infection and for treatment of Zika-linked birth defects.
Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/1817
The outbreak of Zika virus infection in Latin…
Viral Disease Diagnosis Market - Revolutionary Trends 2025 | Cytomegalovirus, De …
Global Viral Disease Diagnosis Market: Snapshot
Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.…
Viral Disease Diagnosis Market to See Huge Growth by 2025 | Measles Virus, Polio …
Global Viral Disease Diagnosis Market: Snapshot
Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.…
Virus Free Corporate Training
Interaction for learning is critical but our customers are slowly starting to realise that this doesn’t necessarily need to take place face to face. Virtual instructor led training (VILT) makes learning more accessible by removing geographical barriers. It helps improve user product adoption, knowledge and career development and eliminates the need for costly and time-consuming travel. Still, there’s often a misconception that in person training is the only type of…
Tick-borne Encephalitis Inactivated Vaccine Market Report 2018: Segmentation by …
Global Tick-borne Encephalitis Inactivated Vaccine market research report provides company profile for Pfizer Inc., Encephalitis Global, Inc., The Cochrane Collaboration, Sonic HealthPlus Pty Ltd., Superdrug Health Clinic, GlaxoSmithKline plc, Merck & Co., Inc., Baxter International Inc., London Travel Clinic and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of…
Oncolytic Virus Therapy Market Oncolytic Virus Therapy Clinical Pipeline Report …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Prologue to Oncolytic Virus
1.1 Outline of Oncolytic Virotherapy
1.2 Trail from Genesis to Biogenetics
Primer of Virotherapy in Malignancies
2.1 Oncolytic Viruses towards Cancer
2.2 Approaches for Targeting Tumor Cells
2.2.1 Pro Apoptotic Targeting
2.2.2 Translational Targeting
2.2.3 Transcriptional Targeting
2.2.4 Transductional Targeting
Mechanism…